Neurones Balance Sheet Health
Financial Health criteria checks 5/6
Neurones has a total shareholder equity of €378.7M and total debt of €37.2M, which brings its debt-to-equity ratio to 9.8%. Its total assets and total liabilities are €623.3M and €244.6M respectively. Neurones's EBIT is €75.9M making its interest coverage ratio -15.5. It has cash and short-term investments of €261.9M.
Key information
9.8%
Debt to equity ratio
€37.24m
Debt
| Interest coverage ratio | -15.5x |
| Cash | €261.86m |
| Equity | €378.68m |
| Total liabilities | €244.64m |
| Total assets | €623.32m |
Recent financial health updates
No updates
Recent updates
Returns On Capital At Neurones (EPA:NRO) Have Hit The Brakes
Apr 26
Slowing Rates Of Return At Neurones (EPA:NRO) Leave Little Room For Excitement
Dec 01If EPS Growth Is Important To You, Neurones (EPA:NRO) Presents An Opportunity
May 18Neurones' (EPA:NRO) Returns Have Hit A Wall
Feb 10Slowing Rates Of Return At Neurones (EPA:NRO) Leave Little Room For Excitement
Oct 26Does Neurones (EPA:NRO) Deserve A Spot On Your Watchlist?
Sep 22Neurones (EPA:NRO) Will Pay A Smaller Dividend Than Last Year
Apr 28Should You Be Adding Neurones (EPA:NRO) To Your Watchlist Today?
Jan 25Returns At Neurones (EPA:NRO) Appear To Be Weighed Down
Jan 06Returns On Capital At Neurones (EPA:NRO) Paint A Concerning Picture
Jul 20Is Neurones S.A. (EPA:NRO) Trading At A 25% Discount?
May 06Some Investors May Be Worried About Neurones' (EPA:NRO) Returns On Capital
Mar 24Neurones S.A.'s (EPA:NRO) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Mar 09The Neurones (EPA:NRO) Share Price Has Gained 54% And Shareholders Are Hoping For More
Feb 16Here's Why Neurones's (EPA:NRO) Statutory Earnings Are Arguably Too Conservative
Jan 25What Percentage Of Neurones S.A. (EPA:NRO) Shares Do Insiders Own?
Jan 11Should Neurones S.A. (EPA:NRO) Be Part Of Your Dividend Portfolio?
Dec 28
Are Neurones S.A. (EPA:NRO) Investors Paying Above The Intrinsic Value?
Dec 15What We Learned About Neurones' (EPA:NRO) CEO Pay
Dec 02Investors Who Bought Neurones (EPA:NRO) Shares Five Years Ago Are Now Up 39%
Nov 17Neurones (EPA:NRO) Is Growing Earnings But Are They A Good Guide?
Jun 30Financial Position Analysis
Short Term Liabilities: NRO's short term assets (€507.7M) exceed its short term liabilities (€209.2M).
Long Term Liabilities: NRO's short term assets (€507.7M) exceed its long term liabilities (€35.4M).
Debt to Equity History and Analysis
Debt Level: NRO has more cash than its total debt.
Reducing Debt: NRO's debt to equity ratio has increased from 0.1% to 9.8% over the past 5 years.
Debt Coverage: NRO's debt is well covered by operating cash flow (203.5%).
Interest Coverage: NRO earns more interest than it pays, so coverage of interest payments is not a concern.